Medical Director, Oncology Clinical Development – Remote

Sumitomo Pharma; Boston (MA); Remote; USD 226,000 - 282,000; Full time

Benefits offered by this job

401(k) plan

Medical insurance

Dental insurance

Vision insurance

Life insurance

Disability insurance

Flexible PTO

Holidays

Sick leave

Job summary

Sumitomo Pharma Co., Ltd. is seeking an Associate Medical Director, Clinical Development – Oncology to lead the design, execution, and management of clinical studies while maintaining strong ties with investigators and key opinion leaders.

The role emphasizes hematologic malignancies and complex patient scenarios. You will contribute to regulatory filings, author clinical sections for INDs/NDAs, and collaborate with Drug Safety & Pharmacovigilance.

Qualifications

• MD/DO or non-US equivalent; residency completion preferred.
• Subspecialty fellowship desirable.
• Experience in blood cancers or solid tumors desirable.
• 0–3 years of pharmaceutical drug development experience required.

Responsibilities

• Lead design and execution of clinical protocols for product development in oncology.
• Provide clinical input to regulatory documents, publications, and investigator interactions.
• Manage study teams, monitor study integrity, and review safety/efficacy data.

Skills

Leadership in clinical teams

Regulatory/compliance knowledge

Scientific/medical communication

Strategic clinical development

Cross-functional collaboration

Education

MD/DO or non-US equivalent

Residency completion

Subspecialty fellowship desirable

Experience in hematologic cancers or solid tumors desirable

Drug development experience 0–3 years

Job description

Sumitomo Pharma Co., Ltd. is seeking an Associate Medical Director, Clinical Development – Oncology to lead the design, execution, and management of clinical studies while maintaining strong ties with investigators and key opinion leaders.

The role emphasizes hematologic malignancies and complex patient scenarios. You will contribute to regulatory filings, author clinical sections for INDs/NDAs, and collaborate with Drug Safety & Pharmacovigilance.